Signifier Medical Technologies Ltd,: Signifier Medical Technologies Raises $35M in Series D Funding Round to Accelerate Commercialization of eXciteOSA Therapy finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Founded by a surgeon and a biotech entrepreneur, Signifier targets $100m fundraise in product development push
29 December 2020 • 12:39pm
A British biotech company started by an ear, nose and throat surgeon and a biomedical entrepreneur is gearing up to launch its snoring device in the US and hopes to raise a further $100m (£74m) next year as it looks to expand.
Signifier Medical Technologies was founded five years ago and is the brainchild of entrepreneur Akhil Tripathi and Professor Anshul Sama. Professor Sama, who is an ENT surgeon in Nottingham and a specialist in snoring and sleep disorders, came up with the idea for the product, called ExciteOSA, after becoming frustrated with existing products to treat snoring-related sleep disorders.
Signifier Medical Technologies Announces Award of UK NHS Supply Chain Tender Copyright 2021 PR Newswire. All Rights Reserved
2020-12-22
Contract award will position Signifier as an approved NHS supplierContract will launch in May 2021, expected to drive UK sales of eXciteOSA® for sleep disordered breathing
BOSTON, and LONDON, Dec. 22, 2020 /PRNewswire/ Â Signifier Medical Technologies ( Signifier or the Company ), an innovator in the sleep disordered breathing market, is pleased to announce the successful award of the UK Non-invasive Ventilation, Sleep Therapy and Sleep Monitoring Tender, which will confirm Signifier as an approved supplier to the UK s National Health Service (NHS).
This contract award gives Signifier direct access to the NHS supply chain, including the relevant coding, inventory and ordering systems, to enter the important UK NHS market. Yasser Zayni, Signifier s Regulatory & Quality Director, was instrumental in the process and commented that